| Filed On | Filing |
|---|---|
| 18 Aug 2026 |
Form 3: Fennell Todd W., 10% owner
No securities owned |
| 11 Aug 2026 |
Form 3: Fennell Todd W., 10% owner
No securities owned |
| 12 Jun 2026 |
Form 3: Isaacs Michael John, General Counsel & Company Sec.
Holds 48,825 shares of Ordinary Shares, par value $0.01 per share |
| 14 May 2026 |
Form 3: Scully William P, 10% owner
Holds 736,000 shares of Ordinary Shares, par value $0.01 per share |
| 10 Apr 2026 |
Form 3: Kingston Anne Evans, Chief Strategy Officer
Holds 66,942 shares of Ordinary Shares, par value $0.01 per share |
| 01 May 2025 |
Form 3: Scully William P, 10% owner
Holds 794,257 shares of Ordinary Shares, par value $0.01 per share |
| 03 Oct 2024 | Form 3: Swanson Chad J., Chief Development Officer |
| 05 Mar 2024 |
Form 3: Ford David A, Chief People Officer
No securities owned |
| 23 Feb 2024 |
Form 3: Welch Daniel G, Director
No securities owned |
| 19 May 2023 |
Form 3: Dunn William H. Jr., Director
No securities owned |
| 02 Sep 2022 |
Form 3: Kim Helen Susan, Director
No securities owned |
| 21 May 2021 |
Form 3: Patel Sanjiv, Director
No securities owned |
| 07 Apr 2021 |
Form 3: Garren Hideki, Chief Medical Officer
No securities owned |
| 04 Mar 2020 |
Form 3: Smith Brandon S., Chief Business Officer
No securities owned |
| 13 Dec 2019 |
Form 3: Nodelman Oleg, Director
Holds 9,426,640 shares of Ordinary Shares |
| 27 Aug 2019 |
Form 3: EcoR1 Capital, Llc, 10% owner
Holds 9,426,640 shares of Ordinary Shares |
| 03 Jul 2019 |
Form 3: Cobb Paula K, Director
No securities owned |
| 03 Jul 2019 |
Form 3: Malecek Michael J, See Remarks
No securities owned |
| 13 Dec 2018 | Form 3: Tripuraneni Radhika, Chief Development Officer |
| 13 Jun 2017 | Form 3: Zago Wagner M., Chief Scientific Officer |
Loading...